第 1 到 63 筆結果,共 63 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients | SHENG-KAI LIANG ; Wu, Chang-Wei; Chang, Ching-I; LI-TA KENG ; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU | Cancer medicine | 0 | 0 | |
2 | 2023 | A deep learning model using chest X-ray for identifying TB and NTM-LD patients: a cross-sectional study | CHIA-JUNG LIU ; Tsai, Cheng Che; LU-CHENG KUO ; Kuo, Po-Chih; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; JIN-YUAN SHIH ; HAO-CHIEN WANG ; CHONG-JEN YU | Insights into imaging | 6 | 4 | |
3 | 2023 | Cone-Beam Computed-Tomography-Derived Augmented Fluoroscopy-Guided Biopsy for Peripheral Pulmonary Nodules in a Hybrid Operating Room: A Case Series | LUN-CHE CHEN ; SHUN-MAO YANG ; Malwade, Shwetambara; HAO-CHUN CHANG ; Chang, Ling-Kai; Chung, Wen-Yuan; JEN-CHUNG KO ; CHONG-JEN YU | Diagnostics (Basel, Switzerland) | 2 | 0 | |
4 | 2023 | Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review | CHIA-HAO CHANG ; LIH-YU CHANG ; JEN-CHUNG KO ; Wen, Yueh-Feng; CHIEN-JEN CHANG ; LI-TA KENG ; PING-HSIEN TSOU ; KAI-LUN YU ; JANN-YUAN WANG ; CHONG-JEN YU | Infectious diseases and therapy | 2 | 1 | |
5 | 2022 | Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells | JEN-CHUNG KO ; Chen, Jyh-Cheng; Hsieh, Jou-Min; Tseng, Pei-Yu; Chiang, Chen-Shan; Liu, Li-Ling; Chien, Chin-Cheng; Huang, I-Hsiang; Chang, Qiao-Zhen; Mu, Bo-Cheng; Lin, Yun-Wei | Biochemical pharmacology | 3 | 2 | |
6 | 2022 | Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells | JEN-CHUNG KO | Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells | 2 | 2 | |
7 | 2022 | Capsaicin Acts Through Reducing P38 MAPK-Dependent Thymidylate Synthase Expression to Enhance 5-Fluorouracil-Induced Cytotoxicity in Human Lung Cancer Cells | Tung C.-L.; Chen J.-C.; JEN-CHANG KO ; Liu L.-L.; Chien C.-C.; Huang I.-H.; Tsao Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W. | Natural Product Communications | 2 | 2 | |
8 | 2021 | Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort | SHENG-KAI LIANG ; LI-TA KENG ; CHIA-HAO CHANG ; Wen, Yueh-Feng; MENG-RUI LEE ; CHING-YAO YANG ; JANN-YUAN WANG ; JEN-CHUNG KO ; JIN-YUAN SHIH ; CHONG-JEN YU | Frontiers in Oncology | 2 | 3 | |
9 | 2021 | Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells | JEN-CHUNG KO | Pharmacology | 0 | 0 | |
10 | 2021 | Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions | KAI-LUN YU ; SHUN-MAO YANG ; Ko, Huan-Jang; Tsai, Hui-Yu; JEN-CHUNG KO ; CHING-KAI LIN ; CHAO-CHI HO ; JIN-YUAN SHIH | Respiration | 19 | 18 | |
11 | 2021 | Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer | PING-HSIEN TSOU ; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; CHIEN-JEN CHANG ; SHENG-KAI LIANG ; Wen Y.-F.; Chang C.-H.; LIH-YU CHANG ; KAI-LUN YU ; CHIA-JUNG LIU ; LI-TA KENG ; MENG-RUI LEE ; JEN-CHUNG KO ; Huang G.-H.; Li Y.-K. | Cancers | 33 | 19 | |
12 | 2021 | Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells | Chen J.-C.; JEN-CHANG KO ; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W. | Pharmacology | 3 | 3 | |
13 | 2021 | Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination | Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHUNG KO ; Chou Y.-T. | Cancer Research | 25 | 25 | |
14 | 2021 | Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation | LI-TA KENG ; SHENG-KAI LIANG ; Tseng C.-P.; Wen Y.-F.; PING-HSIEN TSOU ; CHIA-HAO CHANG ; LIH-YU CHANG ; KAI-LUN YU ; MENG-RUI LEE ; JEN-CHUNG KO | Frontiers in Medicine | 2 | 1 | |
15 | 2020 | Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study | MENG-RUI LEE ; Huang H.-L; LUN-CHE CHEN ; HUNG-CHIH YANG ; JEN-CHUNG KO ; Cheng M.-H; Chong I.-W; LI-NA LEE ; JANN-YUAN WANG ; Dimopoulos G. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 21 | 19 | |
16 | 2020 | Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs | CHIA-HAO CHANG ; Lee C.-H.; JEN-CHUNG KO ; LIH-YU CHANG ; Lee M.-C.; Zhang J.-F.; JANN-YUAN WANG ; JIN-YUAN SHIH ; CHONG-JEN YU | Frontiers in Oncology | 9 | 8 | |
17 | 2020 | Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells | JEN-CHANG KO ; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W. | Pharmacology | 3 | 5 | |
18 | 2020 | Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review | MENG-RUI LEE ; LIH-YU CHANG ; JEN-CHANG KO ; HAO-CHIEN WANG ; Huang Y.-W. | Journal of the Formosan Medical Association | 12 | 8 | |
19 | 2020 | Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study | MENG-RUI LEE ; Lee C.-H.; JANN-YUAN WANG ; Lee S.-W.; JEN-CHANG KO ; LI-NA LEE | Journal of the Formosan Medical Association | 4 | 5 | |
20 | 2019 | Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study | Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHUNG KO ; Lin C.-M.; Hsia T.-C. | Journal of Cancer | 7 | 6 | |
21 | 2019 | Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations | SHENG-KAI LIANG ; JEN-CHUNG KO ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Lung Cancer | 27 | 25 | |
22 | 2019 | Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells | Chen J.-C.; JEN-CHANG KO ; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W. | Toxicology Research | 13 | 10 | |
23 | 2019 | Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells | JEN-CHUNG KO ; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W. | Toxicology | 4 | 3 | |
24 | 2019 | Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study | MENG-RUI LEE ; KAI-LUN YU ; HUNG-YANG KUO ; TSUNG-HAO LIU ; JEN-CHUNG KO ; JAW-SHIUN TSAI ; JANN-YUAN WANG | Scientific Reports | 16 | 13 | |
25 | 2018 | Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study | SHENG-KAI LIANG ; MENG-RUI LEE ; WEI-YU LIAO ; CHAO-CHI HO ; JEN-CHUNG KO ; JIN-YUAN SHIH | Oncotarget | 17 | 0 | |
26 | 2018 | Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study | Liao Y.-C.; WEI-YU LIAO ; Sun J.-L.; JEN-CHANG KO ; CHONG-JEN YU | Supportive Care in Cancer | 22 | 18 | |
27 | 2017 | Cementing an unwanted relationship | Chang C.-H.; LI-TA KENG ; JEN-CHUNG KO | Thorax | 0 | 0 | |
28 | 2017 | Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan | LIH-YU CHANG ; Lee C.-H.; JEN-CHANG KO ; Chang L.-Y.; Lee M.-C.; JANN-YUAN WANG ; CHONG-JEN YU | Cancer Medicine | 8 | 7 | |
29 | 2017 | Tuberculosis contact investigation in an intermediate burden setting: Implications from a large tuberculosis contact cohort in Taiwan | MENG-RUI LEE ; CHENG-MAW HO ; Lee C.-H.; Lee M.-C.; LIH-YU CHANG ; KAI-LUN YU ; JEN-CHUNG KO ; JANN-YUAN WANG ; JANN-TAY WANG ; LI-NA LEE | European Respiratory Journal | 17 | 15 | |
30 | 2017 | Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma | SHENG-KAI LIANG ; MIN-SHU HSIEH ; MENG-RUI LEE ; LI-TA KENG ; JEN-CHUNG KO ; JIN-YUAN SHIH | Oncotarget | 55 | 52 | |
31 | 2017 | Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis | MENG-RUI LEE ; YA-PING HUANG ; Kuo, Yu-Ting; Luo, Chen-Hao; Shih, Yun-Ju; CHIN-CHUNG SHU ; JANN-YUAN WANG ; JEN-CHANG KO ; CHONG-JEN YU ; HSIEN-HO LIN | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 100 | 88 | |
32 | 2016 | Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells | Pan, Chun-Hao; Chang, Ying-Fang; Lee, Ming-Shuo; Wen, B-Chen; JEN-CHUNG KO ; SHENG-KAI LIANG ; Liang, Mei-Chih | BMC cancer | 35 | 32 | |
33 | 2016 | Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression | JEN-CHUNG KO ; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W. | Biochemical Pharmacology | 10 | 10 | |
34 | 2016 | Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells | JEN-CHANG KO ; Chen J.-C.; Wang T.-J.; Zheng H.-Y.; Chen W.-C.; Chang P.-Y.; Lin Y.-W. | Biochemical Pharmacology | 51 | 49 | |
35 | 2016 | Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities | MENG-RUI LEE ; Tsai C.-J.; Hu J.-Y.; Lee S.-W.; JEN-CHUNG KO ; HAO-CHIEN WANG ; CHONG-JEN YU ; LI-NA LEE ; PO-REN HSUEH | Future Microbiology | 7 | 6 | |
36 | 2015 | Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells | JEN-CHANG KO ; Wang T.-J.; Chang P.-Y.; Syu J.-J.; Chen J.-C.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Zheng H.-Y.; Chen W.-C.; Lin Y.-W. | Biochemical Pharmacology | 7 | 5 | |
37 | 2015 | Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells | JEN-CHANG KO ; Chiu H.-C.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Jian Y.-J.; Chang P.-Y.; Wang T.-J.; Lin Y.-W. | Biochemical and Biophysical Research Communications | 9 | 9 | |
38 | 2015 | Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination | MENG-RUI LEE ; Yang C.-Y.; CHIN-CHUNG SHU ; CHING-KAI LIN ; Wen Y.-F.; Lee S.-W.; JEN-CHUNG KO ; JANN-YUAN WANG ; LI-NA LEE ; CHONG-JEN YU | Clinical Microbiology and Infection | 22 | 18 | |
39 | 2015 | Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells | JEN-CHANG KO ; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W. | Basic and Clinical Pharmacology and Toxicology | 22 | 15 | |
40 | 2014 | Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012 | MENG-RUI LEE ; HAO-CHIEN WANG ; CHING-YAO YANG ; CHING-KAI LIN ; HAN-YUEH KUO ; JEN-CHUNG KO ; WANG-HUEI SHENG ; LI-NA LEE ; CHONG-JEN YU ; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 10 | 8 | |
41 | 2014 | Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells | JEN-CHANG KO ; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. | Biochemical Pharmacology | 26 | 25 | |
42 | 2014 | Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates | MENG-RUI LEE ; JEN-CHUNG KO ; SHENG-KAI LIANG ; Lee S.-W.; Yen D.H.-T.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 14 | 13 | |
43 | 2013 | Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells | Chen R.-S.; JEN-CHANG KO ; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Chen H.-J.; Huang Y.-C.; Jian Y.-J.; Lee W.-T.; Lin Y.-W. | Naunyn-Schmiedeberg's Archives of Pharmacology | 9 | 9 | |
44 | 2013 | Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells | JEN-CHANG KO ; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Huang Y.-C.; Chen H.-J.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W. | Lung Cancer | 22 | 20 | |
45 | 2013 | Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells | JEN-CHANG KO ; Huang Y.-C.; Chen H.-J.; Tseng S.-C.; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Weng S.-H.; Chiou R.Y.Y.; Lin Y.-W. | Basic and Clinical Pharmacology and Toxicology | 17 | 16 | |
46 | 2012 | HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells | JEN-CHANG KO ; Chen H.-J.; Huang Y.-C.; Tseng S.-C.; Weng S.-H.; Wo T.-Y.; Huang Y.-J.; Chiu H.-C.; Tsai M.-S.; Chiou R.Y.Y.; Lin Y.-W. | Regulatory Toxicology and Pharmacology | 17 | 18 | |
47 | 2011 | Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine | JEN-CHUNG KO ; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. | Biochemical Pharmacology | 29 | 25 | |
48 | 2011 | Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells | JEN-CHUNG KO ; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. | Journal of Pharmacology and Experimental Therapeutics | 19 | 20 | |
49 | 2011 | Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells | JEN-CHUNG KO ; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. | Toxicology and Applied Pharmacology | 35 | 33 | |
50 | 2010 | Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W. | Biochemical Pharmacology | 71 | 62 | |
51 | 2010 | Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 | JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. | Lung Cancer | 48 | 43 | |
52 | 2009 | The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells | JEN-CHUNG KO ; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. | Lung Cancer | 9 | 9 | |
53 | 2009 | Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation | Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHUNG KO ; Lin Y.-W. | Experimental Cell Research | 28 | 26 | |
54 | 2009 | Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W. | Molecular Cancer Research | 45 | 40 | |
55 | 2008 | Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells | JEN-CHUNG KO ; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. | Carcinogenesis | 55 | 54 | |
56 | 2008 | The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer | JEN-CHUNG KO ; Hong J.-H.; Wang L.-H.; Lin Y.-W. | Experimental Cell Research | 14 | 14 | |
57 | 2008 | Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells | JEN-CHUNG KO ; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. | Molecular Cancer Therapeutics | 38 | 35 | |
58 | 2005 | Disseminated coccidioidomycosis [8] | Wang C.-Y.; JIH-SHUIN JERNG ; JEN-CHUNG KO ; Lin M.-F.; Hsiao C.-H.; LI-NA LEE ; PO-REN HSUEH ; Kuo S.-H. | Emerging Infectious Diseases | 15 | 12 | |
59 | 2004 | Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia | JEN-CHUNG KO ; Wang Y.-T.; Yang J.-L. | Experimental Cell Research | 18 | 14 | |
60 | 1994 | Superior vena cava syndrome: Rapid histologic diagnosis by ultrasound-guided transthoracic needle aspiration biopsy | JEN-CHUNG KO ; PAN-CHYR YANG ; ANG YUAN ; Chang D.-B.; CHONG-JEN YU ; HUEY-DONG WU ; LI-NA LEE ; Kuo S.-H.; KWEN-TAY LUH | American Journal of Respiratory and Critical Care Medicine | 21 | 11 | |
61 | 1994 | Panhypopituitarism caused by solitary parasellar metastasis from lung cancer | JEN-CHANG KO ; PAN-CHYR YANG ; TIEN-SHANG HUANG ; KUN-HUEI YEH ; Kuo S.-H.; KWEN-TAY LUH | Chest | 19 | 17 | |
62 | 1994 | Ultrasonographic evaluation of peridiaphragmatic lesions: A prospective study | JEN-CHANG KO ; PAN-CHYR YANG ; Chang D.-B.; CHONG-JEN YU ; LI-NA LEE ; Kuo S.-H.; KWEN-TAY LUH | Journal of Medical Ultrasound | 6 | ||
63 | 1992 | Lobar bronchioloalveolar carcinoma: an ultrasound study. | JEN-CHUNG KO ; PAN-CHYR YANG ; KWEN-TAY LUH ; Kuo S.H.; Chang D.B.; CHONG-JEN YU | Journal of the Formosan Medical Association = Taiwan yi zhi | 3 | 0 |